These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 31621660)
1. Drug treatment presentations at a treatment centre in southern Nigeria (2015-2018): Findings and implications for policy and practice. James BO; Olotu SO; Ayilara OO; Arigbede OO; Anozie GI; Ogiku HO; Ariyo JO; Efiong V; Adeyelu AO; Oni MA; Odu DO Niger Postgrad Med J; 2019; 26(4):211-215. PubMed ID: 31621660 [TBL] [Abstract][Full Text] [Related]
2. Trends in sociodemographic and drug abuse variables in patients with alcohol and drug use disorders in a Nigerian treatment facility. Adamson TA; Onifade PO; Ogunwale A West Afr J Med; 2010; 29(1):12-8. PubMed ID: 20496332 [TBL] [Abstract][Full Text] [Related]
3. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting]. Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408 [TBL] [Abstract][Full Text] [Related]
4. Patterns of adolescent psychoactive substance use and abuse in Benin City, Nigeria. Pela OA Adolescence; 1989; 24(95):569-74. PubMed ID: 2801280 [TBL] [Abstract][Full Text] [Related]
5. Admissions for drug and alcohol-related problems in Nigerian psychiatric care facilities in one year. Ohaeri JU; Odejide OA Drug Alcohol Depend; 1993 Jan; 31(2):101-9. PubMed ID: 8382147 [TBL] [Abstract][Full Text] [Related]
6. Patterns and factors of problematic marijuana use in the Canadian population: Evidence from three cross-sectional surveys. Bonner WIA; Andkhoie M; Thompson C; Farag M; Szafron M Can J Public Health; 2017 Jun; 108(2):e110-e116. PubMed ID: 28621645 [TBL] [Abstract][Full Text] [Related]
7. A review of the incidence of nonprescription psychoactive substance use/misuse in Nigeria. Omoluabi PF Int J Addict; 1995 Mar; 30(4):445-58. PubMed ID: 7607778 [TBL] [Abstract][Full Text] [Related]
8. [Which psychiatric comorbidities in cannabis dependence during adolescence? Comparison of outpatients and controls]. Dorard G; Bungener C; Phan O; Edel Y; Corcos M; Berthoz S Encephale; 2018 Feb; 44(1):2-8. PubMed ID: 27637871 [TBL] [Abstract][Full Text] [Related]
9. [Old and new long stay patients in French psychiatric institutions: results from a national random survey with two-year follow-up]. Chapireau F Encephale; 2005; 31(4 Pt 1):466-76. PubMed ID: 16389714 [TBL] [Abstract][Full Text] [Related]
10. Substance abuse, health and social welfare in Africa: an analysis of the Nigerian experience. Obot IS Soc Sci Med; 1990; 31(6):699-704. PubMed ID: 2237512 [TBL] [Abstract][Full Text] [Related]
11. Does the 'gateway' matter? Associations between the order of drug use initiation and the development of drug dependence in the National Comorbidity Study Replication. Degenhardt L; Chiu WT; Conway K; Dierker L; Glantz M; Kalaydjian A; Merikangas K; Sampson N; Swendsen J; Kessler RC Psychol Med; 2009 Jan; 39(1):157-67. PubMed ID: 18466664 [TBL] [Abstract][Full Text] [Related]
12. Stay in residential facilities and mental health care as predictors of readmission for patients with substance use disorders. Moos RH; Moos BS Psychiatr Serv; 1995 Jan; 46(1):66-72. PubMed ID: 7895125 [TBL] [Abstract][Full Text] [Related]
13. Correlates of cannabis and other illicit drugs use among secondary school adolescents in Nigeria. Mehanović E; Virk HK; Akanidomo I; Pwajok J; Prichard G; van der Kreeft P; Vigna-Taglianti F; Drug Alcohol Depend; 2020 Jan; 206():107457. PubMed ID: 31786400 [TBL] [Abstract][Full Text] [Related]
14. [Cannabis cessation interventions offered to young French users: predictors of follow-up]. Abdoul H; Le Faou AL; Bouchez J; Touzeau D; Lagrue G Encephale; 2012 Apr; 38(2):141-8. PubMed ID: 22516272 [TBL] [Abstract][Full Text] [Related]
15. Occurrence of comorbid substance use disorders among acute psychiatric inpatients at Stikland Hospital in the Western Cape, South Africa. Weich L; Pienaar W Afr J Psychiatry (Johannesbg); 2009 Aug; 12(3):213-7. PubMed ID: 19750250 [TBL] [Abstract][Full Text] [Related]
16. The characteristics and patterns of utilization of healthcare services among Omanis with substance use disorders attending therapy for cessation. Al Wahaibi N; Al Lawati A; Al Ruqeishy F; Al Khatri A; Al-Farsi Y; Juma TMA; Al Hinai F; Al-Sibani N; Mahadevan S; Al-Adawi S PLoS One; 2019; 14(1):e0210532. PubMed ID: 30703131 [TBL] [Abstract][Full Text] [Related]
17. Profile of young people attending alcohol and other drug treatment services in Aotearoa, New Zealand: clinical file search. Schroder R; Sellman D; Frampton C; Deering D Aust N Z J Psychiatry; 2008 Nov; 42(11):963-8. PubMed ID: 18941961 [TBL] [Abstract][Full Text] [Related]
18. Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007-2014. Neicun J; Yang JC; Shih H; Nadella P; van Kessel R; Negri A; Czabanowska K; Brayne C; Roman-Urrestarazu A PLoS One; 2020; 15(10):e0241056. PubMed ID: 33125395 [TBL] [Abstract][Full Text] [Related]
19. Which substance abuse treatment facilities offer dual diagnosis programs? Mojtabai R Am J Drug Alcohol Abuse; 2004 Aug; 30(3):525-36. PubMed ID: 15540491 [TBL] [Abstract][Full Text] [Related]
20. Probability and correlates of dependence among regular users of alcohol, nicotine, cannabis, and cocaine: concurrent and prospective analyses of the National Epidemiologic Survey on Alcohol and Related Conditions. Cougle JR; Hakes JK; Macatee RJ; Zvolensky MJ; Chavarria J J Clin Psychiatry; 2016 Apr; 77(4):e444-50. PubMed ID: 27137428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]